Agree To Buy Biogen At $160, Earn 6.1% Using Options

Investors eyeing a purchase of Biogen Inc (BIIB) stock, but cautious about paying the going market price of $284.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $160 strike, which has a bid at the time of this writing of $9.80..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.